Grants and Contributions:

Title:

E! 13266 - UK-NitroGelCap: Development of an Enhanced Soft Gel Encapsulation Process That Reduces Product Exposure to Oxygen

Agreement Number:

937378

Agreement Value:

$80,713.00

Agreement Date:

Oct 21, 2019 - Nov 30, 2021

Description:

E! 13266 - UK-NitroGelCap: The two partners are Neurodyn Life Sciences (NLS), a Canadian partner producing a nutraceutical to improve brain health, and the project lead firm Agroceutical Products (APL), a British company involved in producing Galanthamine, an active from Daffodils, with expertise in formulation of pharmaceuticals and other actives. The technology development will provide enhanced product stability by protecting oxidation sensitive components of brain active dietary supplements from oxidation during the processes required for manufacturing (MFG) and post MFG (packaged) goods.

Organization:

National Research Council Canada

Expected Results:

The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization

Location:

Charlottetown, Prince Edward Island, CA C1A 4P3

Reference Number:

172-2019-2020-Q3-937378

Agreement Type:

Contribution

Report Type:

Grants and Contributions

Recipient Business Number:

841463342

Recipient Type:

For-profit organization

Additional Information:

This agreement has been amended 1 time(s). The end date of this agreements has been modified by 61 days.

Amendment Date

Oct 20, 2021

Recipient's Legal Name:

Neurodyn Life Sciences Inc.

Federal Riding Name:

Charlottetown

Federal Riding Number:

11002

Program:

Industrial Research Assistance Program – Contributions to Firms

Program Purpose:

Coverage:

IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.

NAICS Code:

325410

Amendments:

See Amendments